The Comprehensive Guide to Hepatitis Advances provides the most up-to-date information on all types of hepatitis in one resource. Coverage spans hepatitis in all forms (viral, alcoholic, metabolic, drug, autoimmune, etc.), showing the implications of current research in clinical practice and discussing future research directions. Discussions focus on the scientific advancements in understanding the disease process and in the treatment of different groups of hepatitis. This reference is perfect for basic science researchers in the field of hepatology; practicing gastroenterologists and…mehr
The Comprehensive Guide to Hepatitis Advances provides the most up-to-date information on all types of hepatitis in one resource. Coverage spans hepatitis in all forms (viral, alcoholic, metabolic, drug, autoimmune, etc.), showing the implications of current research in clinical practice and discussing future research directions. Discussions focus on the scientific advancements in understanding the disease process and in the treatment of different groups of hepatitis. This reference is perfect for basic science researchers in the field of hepatology; practicing gastroenterologists and hepatologists as well as primary care physicians attending to liver disease; and medical residents undergoing specialist training in gastroenterology and hepatology.
?Section 1:?HEPATITIS: ADVANCES IN CLINICAL EVALUATION 1. Noninvasive assessment of liver disease severity: image-related 2. Noninvasive assessments of liver disease severity based on biomarkers 3. Conventional liver imaging in hepatitis 4. Nutrition in liver disease Section II: VIRAL HEPATITIS 5. Antivirals against hepatitis viruses: basic mechanisms 6. Hepatitis A and hepatitis E 7. Hepatitis B: epidemiology, natural history, and diagnosis 8. Hepatitis B: treatment 9. Hepatitis C: epidemiology, natural history, and diagnosis 10. Hepatitis C: treatment 11. Hepatitis D Section III: HEPATITIS: METABOLIC, ALCOHOL, AND DRUG INDUCED 12. Metabolic-associated fatty liver disease: epidemiology, natural history and diagnosis, current paradigm and definitions for MAFLD 13. Metabolic-associated fatty liver disease: pharmacological management 14. Non-pharmacological treatment approach in patients with metabolic dysfunctionassociated liver disease 15. Alcoholic hepatitis 16. Drug-induced liver injury caused by conventional drugs, using cases based on the Roussel Uclaf causality assessment method 17. Introduction to drug-induced liver injury Section IV: HEPATITIS: CHOLESTATIC, GENETIC, AND AUTOIMMUNE CAUSES 18. Current paradigm and treatment options for autoimmune hepatitis 19. Hereditary hemochromatosis 20. Wilson disease 21. Alpha-1 antitrypsin deficiency Section V: HEPATITIS: INFECTIONS AND SYSTEMIC CAUSES 22. Hepatitis: infections and systemic causes 23. HIV: hepatic manifestations of HIV and antiretroviral therapy 24. Systemic non-infectious hepatitis 25. Concurrent HCV or fatty liver in patients with chronic hepatitis B virus infection Section VI: CHILDHOOD AND PREGNANCY 26. Hepatitis during childhood 27. Hepatitis during pregnancy
?Section 1:?HEPATITIS: ADVANCES IN CLINICAL EVALUATION 1. Noninvasive assessment of liver disease severity: image-related 2. Noninvasive assessments of liver disease severity based on biomarkers 3. Conventional liver imaging in hepatitis 4. Nutrition in liver disease Section II: VIRAL HEPATITIS 5. Antivirals against hepatitis viruses: basic mechanisms 6. Hepatitis A and hepatitis E 7. Hepatitis B: epidemiology, natural history, and diagnosis 8. Hepatitis B: treatment 9. Hepatitis C: epidemiology, natural history, and diagnosis 10. Hepatitis C: treatment 11. Hepatitis D Section III: HEPATITIS: METABOLIC, ALCOHOL, AND DRUG INDUCED 12. Metabolic-associated fatty liver disease: epidemiology, natural history and diagnosis, current paradigm and definitions for MAFLD 13. Metabolic-associated fatty liver disease: pharmacological management 14. Non-pharmacological treatment approach in patients with metabolic dysfunctionassociated liver disease 15. Alcoholic hepatitis 16. Drug-induced liver injury caused by conventional drugs, using cases based on the Roussel Uclaf causality assessment method 17. Introduction to drug-induced liver injury Section IV: HEPATITIS: CHOLESTATIC, GENETIC, AND AUTOIMMUNE CAUSES 18. Current paradigm and treatment options for autoimmune hepatitis 19. Hereditary hemochromatosis 20. Wilson disease 21. Alpha-1 antitrypsin deficiency Section V: HEPATITIS: INFECTIONS AND SYSTEMIC CAUSES 22. Hepatitis: infections and systemic causes 23. HIV: hepatic manifestations of HIV and antiretroviral therapy 24. Systemic non-infectious hepatitis 25. Concurrent HCV or fatty liver in patients with chronic hepatitis B virus infection Section VI: CHILDHOOD AND PREGNANCY 26. Hepatitis during childhood 27. Hepatitis during pregnancy
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Shop der buecher.de GmbH & Co. KG Bürgermeister-Wegele-Str. 12, 86167 Augsburg Amtsgericht Augsburg HRA 13309
